---
figid: PMC7160552__OR-43-06-1737-g02
figtitle: Recent advances in unraveling the molecular mechanisms and functions of
  HOXA11-AS in human cancers and other diseases
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7160552
filename: OR-43-06-1737-g02.jpg
figlink: pmc/articles/PMC7160552/figure/f3-or-43-06-1737/
number: F3
caption: Schematic diagram, introducing in detail the molecular mechanisms, clinical
  values and cell phenotypes affected by HOXA11-AS in different types of tumors, including
  (A) GC, (B) RC, (C) UM, (D) EOC, (E) LSCC, (F) CC, (G) ESCC, (H) osteosarcoma, (I)
  fracture, (J) PE and (K) DM. ‘Upregulation’/‘downregulation’ indicates that the
  expression level of HOXA11-AS in such a tumor was increased/decreased compared with
  normal tissues. The gray arrows (‘bind/sponge’) indicate that HOXA11-AS binds to
  the promoter region of a gene or, as a sponge, binds to a miRNA. The black arrows
  (‘Inf’) indicate that HOXA11-AS affects the phenotypes and the clinical characteristics
  of the cancer under consideration. The blue (‘Pro’) and green (‘In’) arrows indicate
  the promoting or inhibitory effects on the downstream genes, respectively. The purple
  arrows (‘Reg’) indicate the regulatory effects on the downstream pathway. GC, gastric
  cancer; RC, renal cancer; UM, uveal melanoma; EOC, epithelial ovarian cancer; LSCC,
  laryngeal squamous cell carcinoma; ESCC, esophageal squamous cell carcinoma; PE,
  pre-eclampsia; DM, diabetes mellitus; HOXA11-AS, HOXA11 antisense RNA.
papertitle: Recent advances in unraveling the molecular mechanisms and functions of
  HOXA11-AS in human cancers and other diseases.
reftext: Cheng Wei, et al. Oncol Rep. 2020 Jun;43(6):1737-1754.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7140205
figid_alias: PMC7160552__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC7160552__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7160552__OR-43-06-1737-g02.html
  '@type': Dataset
  description: Schematic diagram, introducing in detail the molecular mechanisms,
    clinical values and cell phenotypes affected by HOXA11-AS in different types of
    tumors, including (A) GC, (B) RC, (C) UM, (D) EOC, (E) LSCC, (F) CC, (G) ESCC,
    (H) osteosarcoma, (I) fracture, (J) PE and (K) DM. ‘Upregulation’/‘downregulation’
    indicates that the expression level of HOXA11-AS in such a tumor was increased/decreased
    compared with normal tissues. The gray arrows (‘bind/sponge’) indicate that HOXA11-AS
    binds to the promoter region of a gene or, as a sponge, binds to a miRNA. The
    black arrows (‘Inf’) indicate that HOXA11-AS affects the phenotypes and the clinical
    characteristics of the cancer under consideration. The blue (‘Pro’) and green
    (‘In’) arrows indicate the promoting or inhibitory effects on the downstream genes,
    respectively. The purple arrows (‘Reg’) indicate the regulatory effects on the
    downstream pathway. GC, gastric cancer; RC, renal cancer; UM, uveal melanoma;
    EOC, epithelial ovarian cancer; LSCC, laryngeal squamous cell carcinoma; ESCC,
    esophageal squamous cell carcinoma; PE, pre-eclampsia; DM, diabetes mellitus;
    HOXA11-AS, HOXA11 antisense RNA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GC
  - HOXA11-AS
  - EZH2
  - DNMT1
  - KDM1A
  - MIR1297
  - KLF2
  - PRSS8
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CTNNB1
  - CBLIF
  - INTU
  - TENM1
  - ITK
  - SLC22A3
  - AN
  - NR4A3
  - MMP16
  - NODAL
  - HOXA2
  - RND3
  - ROCK1
  - MROCKI
  - Gc
  - Hoxa11os
  - Ezh2
  - Dnmt1
  - Kdm1a
  - Klf2
  - Prss8
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Ctnnb1
  - Cblif
  - Itk
  - Slc22a3
  - Nr4a3
  - Mmp16
  - Nodal
  - dm
  - Lepr
  - Hoxa2
  - pk
  - Rnd3
  - Rock1
  - Gastric cancer
  - tumor
  - Renal cancer
  - melanoma
  - Epithelial ovarian E Laryngeal squamous
  - carcinoma
  - cancer
  - aroplosis
  - Osteosarcoma
  - Diabetes mellitus
  - DM
  - Fracture
---
